Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Primary Care
•
General Primary Care
How, if at all, have the new IDSA guidelines on UTIs changed your perspective on triaging and/or treating UTIs in your practice?
https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/
Related Questions
Do you have any experience using conolidine supplementation as an adjuvant for pain relief? If so, what brand do you typically recommend?
How do you decide which GLP-1s to prescribe for obesity?
Would you empirically cover anaerobic organisms when treating non-purulent facial cellulitis if oral source (e.g., mucocutaneous lesion) was suspected?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
Do you frequently recommend the HPV vaccination series to patients above 26 years old?
Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?
How do you approach balancing the risks and benefits of elective surgery with patients who have multiple co-morbidities (e.g., frailty, chronic kidney disease, and COPD), when standard risk calculators do not capture the full complexity of their condition?
How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?
What is your go-to strategy for non-opioid management of chronic low back pain in patients with limited access to physical therapy or behavioral health?
What strategy do you find most effective for outpatient induction of buprenorphine in opioid use disorder?
